Provided by Tiger Fintech (Singapore) Pte. Ltd.

AtriCure

29.91
-4.7400-13.68%
Post-market: 29.910.00000.00%18:13 EDT
Volume:2.42M
Turnover:72.41M
Market Cap:1.48B
PE:-36.85
High:31.98
Open:31.18
Low:28.64
Close:34.65
Loading ...

BTIG Reaffirms Their Buy Rating on Atricure (ATRC)

TIPRANKS
·
13 Feb

AtriCure Q4 Adjusted Loss Narrows, Revenue Rises; 2025 Outlook Issued

MT Newswires Live
·
13 Feb

BRIEF-Atricure Inc - Outlook FY Revenue Is Projected To Be Approximately $517 Million To $527 Million

Reuters
·
13 Feb

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings

Zacks
·
13 Feb

AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
13 Feb

AtriCure Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

AtriCure: Q4 Earnings Snapshot

Associated Press Finance
·
13 Feb

AtriCure Sees FY25 Adj. EPS ($0.57)-($0.64); Revenue $517M-$527M.

Benzinga
·
13 Feb

AtriCure Q4 2024 Adj. EPS $(0.08) Beats $(0.23) Estimate, Sales $124.300M Beat $121.842M Estimate

Benzinga
·
13 Feb

AtriCure Inc: Full Year 2025 Adjusted Loss per Share Is Expected to Be in Range of $0.57 to $0.64

THOMSON REUTERS
·
13 Feb

AtriCure Inc - Outlook FY Revenue Is Projected to Be Approximately $517 Mln to $527 Mln

THOMSON REUTERS
·
13 Feb

AtriCure Inc FY2025 Shr View $-0.60, REV View $522.0 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
13 Feb

BRIEF-AtriCure Q4 Adjusted EPS USD -0.08 Vs. IBES Estimate USD -0.23

Reuters
·
13 Feb

AtriCure Outlook FY Adjusted Ebitda USD 42-44 Million

THOMSON REUTERS
·
13 Feb

AtriCure Is Maintained at Overweight by JP Morgan

Dow Jones
·
11 Feb

AtriCure price target raised to $51 from $40 at JPMorgan

TIPRANKS
·
11 Feb

Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS

Zacks
·
11 Feb

AtriCure Price Target Maintained With a $60.00/Share by JMP Securities

Dow Jones
·
10 Feb

JMP Securities Reaffirms Their Buy Rating on Atricure (ATRC)

TIPRANKS
·
10 Feb

Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline

Zacks
·
06 Feb